TeraPore Technologies
Private Company
Total funding raised: $14.5M
Overview
TeraPore Technologies is a private, commercial-stage company providing advanced nanofiltration membranes based on its Intelligent Membrane™ Platform. The company's core innovation is the use of tunable block copolymers to create membranes with highly uniform, engineered pore structures, targeting the demanding purification needs of next-generation biologics and semiconductors. With the launch of its IsoBlock® VF product and a recent $10M funding round, TeraPore is positioned to address scalability and performance gaps in existing filtration markets. The company is led by an experienced team with deep expertise in materials science and bioprocessing commercialization.
Technology Platform
Intelligent Membrane™ Platform using tunable self-assembled block copolymers to create nanofiltration membranes with uniform, engineered pore structures and surface chemistry.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against large, established filtration giants like Merck KGaA (MilliporeSigma), Cytiva (Pall), Sartorius, and 3M in the biopharma space. Differentiation is based on TeraPore's claimed superior pore uniformity, tunability, and fouling resistance derived from its block copolymer platform, rather than incremental improvements to traditional polymer membranes.